Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: May 24, 2018

DrugPatentWatch Database Preview

GLP-1 Receptor Agonist Drug Class List

« Back to Dashboard

Drugs in Drug Class: GLP-1 Receptor Agonist

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novo Nordisk Inc	XULTOPHY 100/3.6	insulin degludec; liraglutide	SOLUTION;SUBCUTANEOUS	208583-001	Nov 21, 2016		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			➤ Sign Up
Novo Nordisk Inc	XULTOPHY 100/3.6	insulin degludec; liraglutide	SOLUTION;SUBCUTANEOUS	208583-001	Nov 21, 2016		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			➤ Sign Up
Novo Nordisk Inc	XULTOPHY 100/3.6	insulin degludec; liraglutide	SOLUTION;SUBCUTANEOUS	208583-001	Nov 21, 2016		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			➤ Sign Up
Novo Nordisk Inc	XULTOPHY 100/3.6	insulin degludec; liraglutide	SOLUTION;SUBCUTANEOUS	208583-001	Nov 21, 2016		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y	Y		➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys

Harvard Business School

Deloitte

Fuji

Medtronic

US Department of Justice

Cerilliant

QuintilesIMS

Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.